BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20197511)

  • 1. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.
    Leonardi RA; Kransdorf EP; Simel DL; Wang A
    Circ Cardiovasc Interv; 2010 Apr; 3(2):97-104. PubMed ID: 20197511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.
    ten Cate FJ; Soliman OI; Michels M; Theuns DA; de Jong PL; Geleijnse ML; Serruys PW
    Circ Heart Fail; 2010 May; 3(3):362-9. PubMed ID: 20332420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA; Liebregts M; Steggerda RC; Schinkel AF; Willems R; Ten Cate FJ; van Cleemput J; Ten Berg JM; Michels M
    JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
    Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.
    Liebregts M; Vriesendorp PA; Mahmoodi BK; Schinkel AF; Michels M; ten Berg JM
    JACC Heart Fail; 2015 Nov; 3(11):896-905. PubMed ID: 26454847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
    Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.
    Jensen MK; Prinz C; Horstkotte D; van Buuren F; Bitter T; Faber L; Bundgaard H
    Heart; 2013 Jul; 99(14):1012-7. PubMed ID: 23644300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
    Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you.
    Nishimura RA; Ommen SR
    Circ Cardiovasc Interv; 2010 Apr; 3(2):91-3. PubMed ID: 20407109
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.
    Osman M; Kheiri B; Osman K; Barbarawi M; Alhamoud H; Alqahtani F; Alkhouli M
    Clin Cardiol; 2019 Jan; 42(1):190-197. PubMed ID: 30421437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
    Singh K; Qutub M; Carson K; Hibbert B; Glover C
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):107-15. PubMed ID: 26526299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Yokoyama Y; Shimoda T; Shimada YJ; Shimamura J; Akita K; Yasuda R; Takayama H; Kuno T
    Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36782361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alcohol septal ablation and hypertrophic cardiomyopathy].
    Kimmelstiel C; Krishnamurthy B; Weintraub A; Kapur N
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1074-7. PubMed ID: 20193175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.
    Balt JC; Wijffels MC; Boersma LV; Wever EF; ten Berg JM
    Heart; 2014 Dec; 100(23):1865-70. PubMed ID: 25073885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does myectomy convey survival benefit in hypertrophic cardiomyopathy?
    Woo A; Rakowski H
    Heart Fail Clin; 2007 Jul; 3(3):275-88. PubMed ID: 17723936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.